Investor Type | Firm |
Industries | BioTech • HealthTech (& Fitness) • Healthcare (& Wellness) |
Investing | Germany |
Investment Range | $2,450,000 - $2,450,000 |
BioM Biotech Cluster Development, located in Munich, Germany, is a venture capital firm founded in 1997. They specialize in funding companies operating within the biotechnology and pharmaceutical sectors. They aim to foster the growth of innovative companies in the field of life sciences by creating a supportive ecosystem. This is achieved through various initiatives such as facilitating partnerships between startups and established entities, providing resources and infrastructure, and offering mentoring and support services. Their investment strategy is centered around strengthening the biotech cluster in Bavaria by contributing to projects that have the potential to advance medical innovation. Notable aspects of their engagement include cross-cluster projects that merge biotechnology with other emerging technologies such as AI and nanotechnology, as well as internationalization assistance for companies within the cluster. They are involved in Bavarian Genomes and DigiMed Bayern, among other significant initiatives, and organize events like the Pharmagipfel dialogue between politics and the pharmaceutical industry and BayOConnect, a forum for biotech and life science. They advocate for welcoming international companies and talents to Bavaria and offer services tailored to the sector such as discount on laboratory supplies, scouting and partnering, funding advice, room rentals for seminars and marketing. Their minimum and maximum investment amount is €2,450,000 which underlines their commitment to substantial support of target companies. Additionally, BioM strives to facilitate job connections through their job exchange platform and welcomes companies to join their extensive biotech database.